
Alpha Profiles · Company Profile
Akebia Therapeutics, Inc.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/akebia-therapeutics-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: AKBA
- Verification
- Partially verified
- Last reviewed
- 2026-10-16T13:52:54.339891+00:00
Overview
Alpha's canonical identity and public leadership record for Akebia Therapeutics, Inc..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
5 public recordsSenior Vice President, Chief Legal Officer and Secretary
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- AKBA DEF 14A executive officersApr 28, 2026
Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- AKBA DEF 14A executive officersApr 28, 2026
President, Chief Executive Officer and Director
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- AKBA DEF 14A executive officersApr 28, 2026
Senior Vice President, Chief Commercial Officer
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- AKBA DEF 14A executive officersApr 28, 2026
Senior Vice President, Chief Research Development and Medical Officer
- State
- confirmed
- Effective
- From Apr 28, 2026
- Confidence
- 94%
- Evidence
- AKBA DEF 14A executive officersApr 28, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 16, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
8 public records- State
- confirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- Akebia Therapeutics, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- Akebia Therapeutics, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2013
- Confidence
- 85%
- Evidence
- Akebia Therapeutics, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Akebia Therapeutics, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- Akebia Therapeutics, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Akebia Therapeutics, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Akebia Therapeutics, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- Akebia Therapeutics, Inc. DEF 14A 2025-04-29Apr 29, 2025
Committees
3 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Michael Rogers
- Members
- Michael Rogers (Chair); LeAnne M. Zumwalt; Ronald E. Frieson
Compensation
- Chair
- Cynthia Smith
- Members
- Cynthia Smith (Chair); Adrian Adams
Nominating and Governance
- Chair
- Ronald E. Frieson
- Members
- Ronald E. Frieson (Chair); LeAnne M. Zumwalt
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-16T13:52:54.339891+00:00


